JRC Publications Repository

JRC Publications Repository >

Browsing by Author BRUCHERTSEIFER Frank

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:   
Sort by: In order: Results/Page Authors/Record:
Showing results 59 to 78 of 87
Publication YearTitleAuthor(s), Editor(s), Other Contributor(s)Publication Type
2008Radiofungicidal Effects of External Gamma Radiation and Antibody-Targeted Beta and Alpha Radiation on Cryptococcus neoformansBRYAN R. A.; MORGENSTERN Alfred; BRUCHERTSEIFER Frank; CASADEVALL A.; DADACHOVA E.Articles in Journals
2009Radioimmunotherapy Is Effective Against High-Inoculum Cryptococcus Neoformans Infection in Mice and Does Not Select for Radiation-Resistant Cryptococcal CellsBRYAN R. A.; JIANG Z.; HUANG X.; MORGENSTERN Alfred; BRUCHERTSEIFER Frank; SELLERS R.; CASADEVALL A.; DADACHOVA E.Articles in Journals
2010Radioimmunotherapy is More Effective than Antifungal Treatment in Experimental Cryptococcal InfectionBRYAN R. A.; JIANG Z.; HOWELL Roberta; MORGENSTERN Alfred; BRUCHERTSEIFER Frank; CASADEVALL A.; DADACHOVA E.Articles in Journals
2013Radioimmunotherapy of Cryptococcus neoformans Spares Bystander Mammalian CellsBRYAN R. A.; JIANG Z.; MORGENSTERN Alfred; BRUCHERTSEIFER Frank; Casadevall Arturo; DADACHOVA E.Articles in Journals
2009Radioimmunotherapy of human bladder cancer in a nude mouse model comparing Bi-213-anti-EGFR-MAb and Th-226-anti-EGFR-MAbPFOST B.; MORGENSTERN Alfred; SEIDL C.; BRUCHERTSEIFER Frank; AUTENRIETH M.; APOSTOLIDIS Christos; ABBAS Kamel; SENEKOWITSCH-SCHMIDTKE R.Contributions to Conferences
2012Radioimmunotherapy of pancreatic cancer with 213Bi-labeled antibodies to intranuclear histonesDADACHOVA E.; BRYAN R. A.; JIANG Z.; JANDL T; STRAUSS J; KOBA W; SELLERS R.; MORGENSTERN Alfred; BRUCHERTSEIFER Frank; EPSTEIN AContributions to Conferences
2009Radiolabeled Antibodies to Bacillus Anthracis Toxins are Bactericidal and Partially Therapeutic in Experimental Murine AnthraxRIVERA J.; NAKOUZI A.s.; MORGENSTERN Alfred; BRUCHERTSEIFER Frank; DADACHOVA E.Articles in Journals
2012Radiopeptidtherapie des Ovarialkarzinoms mit Alphastrahlern: Verbesserte Tumorkontrolle durch Kombination von 213Bi-DTPA-F3 mit Taxol bei irreversiblen Zellzyklusarrest von Ovarialkarzinomzellen in der G2/M-PhaseSEIDL C.; VALLON M.; BLECHERT B.; GÄRTNER Florian; BRUCHERTSEIFER Frank; MORGENSTERN Alfred; ESSLER M.Contributions to Conferences
2013Retention studies in polymer vesicles of recoiling atoms as a result of alpha decayWANG G.; VAN BUEREN J; MORGENSTERN Alfred; BRUCHERTSEIFER Frank; WOLTERBEEK H.th.; MENDES E; DENKOVA A.g.Contributions to Conferences
2014Retention studies of recoiling daughter nuclides of 225Ac in polymer vesiclesWANG G.; DE KRUIJFF R. M.; ROL A; THIJSSEN L.; MENDES E; MORGENSTERN Alfred; BRUCHERTSEIFER Frank; STUART M.c.a.; WOLTERBEEK H.th.; DENKOVA A.g.Articles in Journals
2009Spectroscopic Study of the Interaction of U(VI) with Transferrin and Albumin for Speciation of U(VI) under Blood Serum ConditionsMONTAVON Gilles; APOSTOLIDIS Christos; BRUCHERTSEIFER Frank; REPINC Urska; MORGENSTERN AlfredArticles in Journals
2013Substance P - nanozeolite labeled with 224Ra and 225Ra - new potential radiobioconjugate for internal alpha therapyLESZCZUK Edyta; PIOTROWSKA A; KOŹMIŃSKI P; BILEWICZ Aleksander; MORGENSTERN Alfred; BRUCHERTSEIFER FrankContributions to Conferences
2012Synthesis and in vitro evaluation of 225Ac-DOTA-SubstanceP for targeted alpha therapy of glioblastoma multiformeMAJKOWSKA AGNIESZKA; BRUCHERTSEIFER Frank; WEIS Mirjam; BONELLI Milton; LAURENZA M; APOSTOLIDIS Christos; MORGENSTERN AlfredContributions to Conferences
2013Synthesis of 213Bi-DOTATOC for peptide receptor a-therapy of GEP-NET patients refractory to β-therapyBRUCHERTSEIFER Frank; MORGENSTERN Alfred; APOSTOLIDIS Christos; GIESEL Frederik; MIER Walter; HABERKORN Uwe; KRATOCHWIL ClemensContributions to Conferences
2012Synthesis of 213Bi-DOTATOC for peptide receptor alpha-therapy of GEP-NET patients refractory to beta therapyMORGENSTERN Alfred; BRUCHERTSEIFER Frank; APOSTOLIDIS Christos; GIESEL Frederik; MIER Walter; HABERKORN Uwe; KRATOCHWIL ClemensContributions to Conferences
2013Targeted alpha therapy of glioblastoma multiforme with 213Bi-substance PMORGENSTERN Alfred; KROLICKI Leszek; KUNIKOWSKA Jolanta; KOCIARA Henryk; KROLICKI B; JAKUCINSKI M; MIKOŁAJCZAK Renata; PAWLAK Dariusz; APOSTOLIDIS Christos; BRUCHERTSEIFER FrankContributions to Conferences
2013Targeted alpha therapy of glioblastoma multiforme: initial clinical experience with 213Bi-substance PMORGENSTERN Alfred; KROLICKI Leszek; KUNIKOWSKA Jolanta; KOZIARA H; KROLICKI B; JAKUCINSKI M; MIKOŁAJCZAK Renata; PAWLAK Dariusz; APOSTOLIDIS Christos; BRUCHERTSEIFER FrankContributions to Conferences
2011Targeted alpha therapy with 213BiMORGENSTERN Alfred; BRUCHERTSEIFER Frank; APOSTOLIDIS ChristosArticles in Journals
2010Targeted Alpha-Radionuclide Therapy of Functionally Critical Located Gliomas with 213Bismuth-DOTA-[Thi8,Met(O2)11]-Substance P - A Pilot TrialCORDIER D.; FORRER F.; BRUCHERTSEIFER Frank; MORGENSTERN Alfred; APOSTOLIDIS Christos; GOOD S.; MÜLLER-BRAND J.; MÄCKE H.; REUBI Jean-Claude; MERLO A.Articles in Journals
2013Targeting aberrant DNA double strand break repair in triple negative breast cancer with alpha particle emitter radiolabeled anti-EGFR antibodySONG H.; HOBBS Robert F.; SHAO Chunbo; BRUCHERTSEIFER Frank; MORGENSTERN Alfred; DEWEESE Tl; SGOUROS G.; HEDAYATI MohammadArticles in Journals
Showing results 59 to 78 of 87

 

The mission of the JRC is to provide customer-driven scientific and technical support for the conception, development, implementation and monitoring of EU policies. As a service of the European Commission, the JRC functions as a reference centre of science and technology for the Union. Close to the policy-making process, it serves the common interest of the Member States, while being independent of special interests, whether private or national.
Powered by DSpace
Top